BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35321843)

  • 1. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials.
    Saleh SAK; Santos HO; Găman MA; Cerqueira HS; Zaher EA; Alromaih WR; Arafat NS; Adi AR; Adly HM; Alyoubi R; Alyahyawi N; Kord-Varkaneh H
    Clin Nutr ESPEN; 2024 Feb; 59():70-80. PubMed ID: 38220409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium-glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
    Xing B; Zhao Y; Dong B; Zhou Y; Lv W; Zhao W
    J Diabetes Investig; 2020 Sep; 11(5):1238-1247. PubMed ID: 32083798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
    Gkiourtzis N; Michou P; Moutafi M; Glava A; Cheirakis K; Christakopoulos A; Vouksinou E; Fotoulaki M
    Eur J Pediatr; 2023 Nov; 182(11):4795-4806. PubMed ID: 37639015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
    Malik A; Malik M; Qureshi S
    Can Liver J; 2024 Feb; 7(1):40-53. PubMed ID: 38505782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis.
    Li D; Fu N; Wu H
    Clin Exp Hepatol; 2023 Dec; 9(4):396-404. PubMed ID: 38774194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsamos G; Kalopitas G; Evripidou K; Vasdeki D; Koufakis T; Kanavas V; Antza C; Germanidis G; Chourdakis M
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease.
    Ma Q; Liao X; Shao C; Lin Y; Wu T; Sun Y; Feng ST; Ye J; Zhong B
    BMC Gastroenterol; 2021 May; 21(1):215. PubMed ID: 33971815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.
    Li S; Duan F; Li S; Lu B
    Ann Hepatol; 2024; 29(2):101174. PubMed ID: 38579127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Sohouli MH; Bagheri SE; Fatahi S; Rohani P
    Obes Sci Pract; 2024 Jun; 10(3):e758. PubMed ID: 38682153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials.
    Liu H; Li Y; Jin Y; Li X; Wang D; Yu X; Jiang Z; Yin G; Chen S; Zhang X; Meng D; Yu W; Jiang W; Zhang F
    Phytother Res; 2024 Jun; ():. PubMed ID: 38886838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials.
    Marey MM; Belal M; Awad AA; Rabea EM; Hassan MA; Abbas AW; Nashwan AJ
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102357. PubMed ID: 38688423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different exercise modalities on nonalcoholic fatty liver disease: a systematic review and network meta-analysis.
    Xue Y; Peng Y; Zhang L; Ba Y; Jin G; Liu G
    Sci Rep; 2024 Mar; 14(1):6212. PubMed ID: 38485714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Intermittent Fasting on Liver Function Tests: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Ranjbar M; Shab-Bidar S; Mohammadi H; Djafarian K
    Nutr Rev; 2024 Jun; ():. PubMed ID: 38917447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
    Mahmoud A; Mohamed I; Abuelazm M; Ahmed AAS; Saeed A; Elshinawy M; Almaadawy O; Abdelazeem B
    Proc (Bayl Univ Med Cent); 2024; 37(4):603-612. PubMed ID: 38910819
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of anthocyanins supplementation on liver enzymes: A systematic review and meta-analysis of randomized clinical trials.
    Sangsefidi ZS; Mozaffari-Khosravi H; Sarkhosh-Khorasani S; Hosseinzadeh M
    Food Sci Nutr; 2021 Jul; 9(7):3954-3970. PubMed ID: 34262751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of mobile health applications on clinical outcomes and health behaviors in patients with coronary heart disease: A systematic review and meta-analysis.
    Zhu Y; Zhao Y; Wu Y
    Int J Nurs Sci; 2024 Apr; 11(2):258-275. PubMed ID: 38707688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis.
    Yang Y; Yang L; Wu J; Hu J; Wan M; Bie J; Li J; Pan D; Sun G; Yang C
    Clin Nutr; 2024 Jun; 43(6):1224-1239. PubMed ID: 38643738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of resistance exercise on patients with chronic kidney disease.
    Chen CC; Huang YY; Hua-Zhang ; Xia-Liu ; Li XQ; Long YQ; Chen ZW; Jin T
    BMC Nephrol; 2024 Mar; 25(1):115. PubMed ID: 38532316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of grape-derived products on the serum levels of enzymes mainly produced by the liver: A systematic review and meta-analysis of parallel randomized controlled trials.
    Alhajlah S
    Phytother Res; 2024 May; ():. PubMed ID: 38719548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.